Funding for this research was provided by:
Svenska Forskningsrådet Formas
ALF grants from The Sahlgrenska University Hospital
Text and Data Mining valid from 2018-11-20
Received: 28 November 2017
Accepted: 8 October 2018
First Online: 20 November 2018
Ethics approval and consent to participate
: Breast cancer tissue was obtained with written informed consent through Sahlgrenska University Hospital and all patients gave written consent for the use of material for research purposes. The study was approved by the Regional Ethic Authority in Gothenburg (reference 515–12). Mice were housed in Experimental Biomedicine Animal Unit, University of Gothenburg and the study was approved by the Animal Research Ethics Committee of Gothenburg, and proper animal experimentation guidelines were followed.
: All authors read and approved the final manuscript.
: GL is the patent owner of PCT/EP2015/056663, agents and methods for treatment of cancer. AS is a shareholder of TATAA Biocenter. No other potential conflicts of interest were disclosed.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.